Total planned funding: $282,881,777
Allocations
Countries/Regions
| Cameroon | $282,881,777 |
Organizational Types
| Unknown | $104,847,475 |
| FBO | $71,443,142 |
| NGO | $35,163,083 |
| Own Agency | $23,988,126 |
| Private Contractor | $23,372,260 |
| University | $12,715,278 |
| Implementing Agency | $8,859,877 |
| Host Country Government Agency | $1,200,000 |
| Other USG Agency | $874,583 |
| Multi-lateral Agency | $417,953 |
Program Areas
| Treatment | $104,628,987 |
| Governance and Systems | $69,843,709 |
| Care | $45,488,189 |
| Prevention | $31,261,314 |
| Testing | $15,913,903 |
| Management and Operations | $15,745,675 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $85,099,679 |
| OHSS: Health Systems Strengthening | $59,495,203 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,578,591 |
| HVCT: Testing: HIV Testing and Counseling | $15,913,903 |
| HVMS: Management and Operations | $15,745,675 |
| HBHC: Care: Adult Care and Support | $15,110,886 |
| PDTX: Treatment: Pediatric Treatment | $13,651,099 |
| HKID: Care: Orphans and Vulnerable Children | $12,352,867 |
| HVTB: Care: TB/HIV | $11,041,991 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $9,834,234 |
| PDCS: Care: Pediatric Care and Support | $6,982,445 |
| HTXD: Treatment: ARV Drugs | $5,878,209 |
| HLAB: Laboratory Infrastructure | $5,358,237 |
| HVSI: Strategic Information | $4,990,269 |
| HMBL: Biomedical Prevention: Blood Safety | $848,489 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$88,584,752
Countries/Regions
Chemonics International:
$18,185,453
Countries/Regions
CARE International:
$17,136,584
Countries/Regions
USG Aggregated Agencies:
$15,861,003
Countries/Regions